Pro-tumor activities of macrophages in the progression of melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pro-tumor activities of macrophages in the progression of melanoma

Published:2017-04-25 Issue:7 Volume:13 Page:1556-1562
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Wang Huafeng¹^ORCID,Yang Luhong¹,Wang Dong²,Zhang Qi³,Zhang Lijuan⁴

Affiliation:

1. Modern College of Arts and Science, or School of Life Science, Shanxi Normal University, Linfen, China

2. Central Blood Station of Tianjin, Tianjin, China

3. Nankai Hospital, Tianjin, China

4. Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin, China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1312043

Reference74 articles.

1. Organization WH. World cancer report, 2014. WHO Report. Geneva: WHO; 2014; Chapter 5.14.

2. Elie Metchnikoff's and Paul Ehrlich's impact on infection biology

3. Exploring the full spectrum of macrophage activation

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship of microvascular density and tumor-associated macrophages with orofacial squamous cell carcinoma progression;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-10

2. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response;Archives of Dermatological Research;2024-05-25

3. Envoplakin Inhibits Macrophage Polarization by Altering the Inflammatory Tumor Microenvironment of Melanoma Through the RAS / ERK Signaling Pathway;Journal of Inflammation Research;2024-03

4. Lipid-based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

5. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies;Signal Transduction and Targeted Therapy;2023-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3